Julie Gardener
New Member
Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R(+)-Methanandamide and JWH-015: Involvement of CB2
N Olea-Herrero1, D Vara1, S Malagarie-Cazenave1 and I DÃaz-Laviada11Department of Biochemistry and Molecular Biology, School of Medicine, University of Alcalá, Alcalá de Henares, 28871 Madrid, Spain
Correspondence: Professor I DÃaz-Laviada, E-mail: ines.diazlaviada@uah.es
Revised 16 July 2009; Accepted 21 July 2009; Published online 18 August 2009.
British Journal of Cancer (2009) 101, 940–950. doi:10.1038/sj.bjc.6605248 British Journal of Cancer
Abstract
background: We have previously shown that cannabinoids induce growth inhibition and apoptosis in prostate cancer PC-3 cells, which express high levels of cannabinoid receptor types 1 and 2 (CB1 and CB2). In this study, we investigated the role of CB2 receptor in the anti-proliferative action of cannabinoids and the signal transduction triggered by receptor ligation.
methods: The human prostate cancer cell lines, namely PC-3, DU-145 and LNCaP, were used for this study. Cell proliferation was measured using MTT proliferation assay, [3H]-thymidine incorporation assay and cell-cycle study by flow cytometry. Ceramide quantification was performed using the DAG kinase method. The CB2 receptor was silenced with specific small interfering RNA, and was blocked pharmacologically with SR 144528. In vivo studies were conducted by the induction of prostate xenograft tumours in nude mice.
results: We found that the anandamide analogue, R(+)-Methanandamide (MET), as well as JWH-015, a synthetic CB2 agonist, exerted anti-proliferative effects in PC-3 cells. R(+)-Methanandamide- and JWH-015-induced cell death was rescued by treatment with the CB2 receptor antagonist, SR 144528. Downregulation of CB2 expression reversed the effects of JWH-015, confirming the involvement of CB2 in the pro-apoptotic effect of cannabinoids. Further analysing the mechanism of JWH-015-induced cell growth inhibition, we found that JWH-015 triggered a de novo synthesis of ceramide, which was involved in cannabinoid-induced cell death, insofar as blocking ceramide synthesis with Fumonisin B1 reduced cell death. Signalling pathways activated by JWH-015 included JNK (c-Jun N-terminal kinase) activation and Akt inhibition. In vivo treatment with JWH-015 caused a significant reduction in tumour growth in mice.
conclusions: This study defines the involvement of CB2-mediated signalling in the in vivo and in vitro growth inhibition of prostate cancer cells and suggests that CB2 agonists have potential therapeutic interest and deserve to be explored in the management of prostate cancer.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
REVIEWS
Cannabinoids: potential anticancer agents
Nature Reviews Cancer Review (01 Oct 2003)
The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis
Cell Death and Differentiation Review
See all 8 matches for Reviews
NEWS AND VIEWS
Pot of gold for glioma therapy
Nature Medicine News and Views (01 Mar 2000)
RESEARCH
JunD is involved in the antiproliferative effect of Δ 9 -tetrahydrocannabinol on human breast cancer cells
Oncogene Original Article
A pilot clinical study of Δ 9 -tetrahydrocannabinol in patients with recurrent glioblastoma multiforme
British Journal of Cancer Original Article
See all 9 matches for Research
Source: British Journal of Cancer - Abstract of article: Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R(+)-Methanandamide and JWH-015: Involvement of CB2
